362 results on '"Kawaguchi, Shohei"'
Search Results
102. Massive Ascites in a Renal Transplant Patient after Laparoscopic Fenestration of a Lymphocele
- Author
-
Kawaguchi, Shohei, Nohara, Takahiro, Shima, Takashi, Matsuyama, Satoko, Nose, Chikako, Yamahana, Junya, Kadono, Yoshifumi, Seto, Chikashi, Kawabata, Masahiko, and Mizokami, Atsushi
- Subjects
Article Subject - Abstract
Retroperitoneal lymphocele is a common complication of renal transplantation. Here, we report the case of a 67-year-old woman with massive ascites after fenestration surgery for a lymphocele that developed following renal transplantation. She had been on continuous ambulatory peritoneal dialysis for 9 years. Living donor renal transplantation was performed and an intrapelvic lymphocele subsequently developed. The lymphocele did not resolve after aspiration therapy; therefore, laparoscopic fenestration was performed. Although the lymphocele disappeared, massive ascites appeared in its stead. Half a year later, the ascites was surgically punctured, which then gradually resolved and disappeared 6 weeks later. Aspiration therapy should be considered in patients on long-term peritoneal dialysis, although laparoscopic fenestration is safe and effective.
- Published
- 2016
- Full Text
- View/download PDF
103. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study
- Author
-
Shigehara, Kazuyoshi, Sasagawa, Toshiyuki, Doorbar, John, Kawaguchi, Shohei, Kobori, Yoshitomo, Nakashima, Takao, Shimamura, Masayoshi, Maeda, Yuji, Miyagi, Tohru, Kitagawa, Yasuhide, Kadono, Yoshifumi, Konaka, Hiroyuki, Mizokami, Atsushi, Koh, Eitetsu, and Namiki, Mikio
- Subjects
Male ,Urologic Diseases ,Aging ,medicine.medical_specialty ,Hormone Replacement Therapy ,uroflowmetry ,medicine.medical_treatment ,Prostatic Hyperplasia ,Urology ,urologic and male genital diseases ,law.invention ,Randomized controlled trial ,law ,Benign prostate hypertrophy ,Lower urinary tract symptoms ,Surveys and Questionnaires ,Hormone replacement therapy (male-to-female) ,Health Status Indicators ,Humans ,Medicine ,Testosterone ,In patient ,lower urinary tract symptoms ,Aged ,business.industry ,Hypogonadism ,post-voiding residual volume ,Age Factors ,medicine.disease ,Urodynamics ,Androgens ,Disease Progression ,International Prostate Symptom Score ,Geriatrics and Gerontology ,Androgen replacement therapy ,Men's Health ,business ,benign prostate hypertrophy - Abstract
金沢大学附属病院泌尿器科, Purpose. We performed a randomised controlled study regarding the effects of androgen replacement therapy (ART) on lower urinary tract symptoms (LUTS) in hypogonadal men with benign prostate hypertrophy (BPH). Methods. Fifty-two patients with hypogonadism and BPH were randomly assigned to receive testosterone (ART group) as 250 mg of testosterone enanthate every 4 weeks or to the untreated control group. We compared International Prostate Symptom Score (IPSS), uroflowmetry data, post-voiding residual volume (PVR) and systemic muscle volume at baseline and 12 months after treatment. Results. Forty-six patients (ART group, n=23; control, n=23) were included in the analysis. At the 12-month visit, IPSS showed a significant decrease compared with baseline in the ART group (15.7±8.7 vs. 12.5 ± 9.5; p < 0.05). No significant changes were observed in the control group. The ART group also showed improvement in maximum flow rate and voided volume (p < 0.05), whereas no significant improvements were observed in the controls. PVR showed no significant changes in either group. In addition, the ART group showed significant enhancement of mean muscle volume (p < 0.05), whereas no significant changes were seen in the controls. Conclusion. ART improved LUTS in hypogonadal men with mild BPH. © 2010 Informa UK, Ltd.
- Published
- 2010
104. Prostatic Stromal Tumor of Uncertain Malignant Potential Which Was Difficult to Diagnose
- Author
-
Matsuyama, Satoko, Nohara, Takahiro, Kawaguchi, Shohei, Seto, Chikashi, Nakanishi, Yuko, Uchiyama, Akio, and Ishizawa, Shin
- Subjects
Article Subject - Abstract
Here, we report a case of stromal tumor of uncertain malignant potential (STUMP) that was difficult to diagnose. A 53-year-old male was found to have a hard nodule on digital rectal examination; magnetic resonance imaging revealed a large nodule on the left side of the prostate, indicating prostate cancer. However, pathological diagnosis of the biopsy specimen was benign prostatic hyperplasia. Although a papillary tumor in the prostatic urethra was also seen on urethrocystoscopy, the tumor specimen obtained from transurethral resection was not malignant. The tumor in the prostatic urethra recurred only 3 months after transurethral resection, and pathological findings revealed benign hyperplasia not only in the stromal tissue but also in the epithelium; therefore, the prostate tumor was suspected to be STUMP. It took many prostate pathologists a long time to reach the final diagnosis of STUMP. STUMP is a rare benign tumor, difficult to diagnose, and sometimes transforms into stromal sarcoma. Thus, we should consider radical resection in such cases.
- Published
- 2015
- Full Text
- View/download PDF
105. Evaluating urinary incontinence before and after radical prostatectomy using the international consultation on incontinence questionnaire‐short form.
- Author
-
Machioka, Kazuaki, Kadono, Yoshifumi, Naito, Renato, Nakashima, Kazufumi, Iijima, Masashi, Kawaguchi, Shohei, Shigehara, Kazuyoshi, Nohara, Takahiro, Izumi, Kouji, and Mizokami, Atsushi
- Abstract
Aims: To evaluate urinary incontinence using the International Consultation on Incontinence Questionnaire‐Short Form (ICIQ‐SF), daily pad use, and 24‐h pad weight test before and after radical prostatectomy (RP) chronologically, and the correlation between them. Methods: ICIQ‐SF and questions on daily pad use provided subjective, and 24‐h pad weight test for objective evaluation. Results: In total, 258 cases were recruited. The continence rate at 12 months after RP was 67% for no pad use, 87% for security 1 pad/day, and 94% for 1 pad/day. The median ICIQ‐SF total score before and at 1, 3, 6, and 12 months after RP was 0, 10, 7, 5, and 4, respectively. Incontinence patterns differed when comparing ICIQ‐SF results pre‐ and post‐RP. Significant correlation existed between the ICIQ‐SF total score, 24‐h pad weight test, and daily pad use; however, point distribution on each scatter plot varied widely. Comparing results before and at 12 months after RP revealed complete recovery for 35% of patients from the ICIQ‐SF total score, 67% from daily pad use, and 64% from the 24‐h pad weight test. A combination of all 3 showed a recovery of preoperative levels in 29% of patients. Conclusions: ICIQ‐SF was effective and convenient for evaluating UI, including the pattern of UI, after RP. Significant correlation, but wide variations, among ICIQ‐SF, daily pad use, and the 24‐h pad weight test existed. The best evaluation method would be the one that can compare UI status pre‐ and post‐RP using the ICIQ‐SF and 24‐h pad weight test. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
106. SiNx passivated GaN HEMT by plasma enhanced atomic layer deposition
- Author
-
Suzuki, Takayuki, primary, Yamada, Tomiaki, additional, Kawai, Ryosuke, additional, Kawaguchi, Shohei, additional, Zhang, Dongyan, additional, and Iwata, Naotaka, additional
- Published
- 2016
- Full Text
- View/download PDF
107. Usefulness of selective renal artery embolization for urinary fistula following partial nephrectomy: Two case reports
- Author
-
NOHARA, TAKAHIRO, primary, MATSUYAMA, SATOKO, additional, KAWAGUCHI, SHOHEI, additional, MIYAGI, TOHRU, additional, SETO, CHIKASHI, additional, and MOCHIZUKI, KENTARO, additional
- Published
- 2016
- Full Text
- View/download PDF
108. High urinary flow in women with stress incontinence: corrected flow–age nomogram evaluation after a transobturator tape procedure
- Author
-
Kitagawa, Yasuhide, primary, Narimoto, Kazutaka, additional, Urata, Satoko, additional, Kawaguchi, Shohei, additional, Kuribayashi, Masato, additional, and Namiki, Mikio, additional
- Published
- 2016
- Full Text
- View/download PDF
109. Holmium Laser Enucleation of the Prostate With Percutaneous Nephrostomy Into the Transplanted Kidney in Patient With Severe Benign Prostatic Hyperplasia With Vesicoureteral Reflux – A Case Report
- Author
-
Nohara, Takahiro, primary, Matsuyama, Satoko, additional, Shima, Takashi, additional, Kawaguchi, Shohei, additional, and Seto, Chikashi, additional
- Published
- 2016
- Full Text
- View/download PDF
110. A Case Report of Chyloretroperitoneum Post Living-Donor Transplantation.
- Author
-
Kawaguchi, Shohei, Kadono, Yoshifumi, Nohara, Takahiro, Kato, Yuki, Nakagawa, Tomomi, Urata, Satoko, Yaegashi, Hiroshi, Nakashima, Kazufumi, Iijima, Masashi, Shigehara, Kazuyoshi, Izumi, Kouji, and Mizokami, Atsushi
- Subjects
- *
UROLOGICAL surgery , *TRANSPLANTATION of organs, tissues, etc. , *SURGICAL complications , *PARENTERAL feeding , *HYDRONEPHROSIS - Abstract
Chyloretroperitoneum is a rare complication of urological surgery. Here we report a case of chyloretroperitoneum that occurred in a 28-year-old man post living-donor transplantation. Twenty-nine days post transplantation, perirenal fluid collection and hydronephrosis were detected and percutaneous drainage was performed. The fluid was chylous and revealed a very high triglyceride concentration (1,197 mg/dL). Total parenteral nutrition and administration of octreotide were performed, but the leakage did not improve. On the contrary, the drainage fluid gradually increased to 1,600 mL/day, and a laparoscopic fenestration was performed owing to a concern about the adverse effects of massive lymph loss. Ascites temporarily appeared but disappeared 3 months post fenestration. To our knowledge, this is the first case report of pelvic chyloretroperitoneum post living-donor transplantation. Furthermore, if chyloretroperitoneum treatment using diet control or octreotide is ineffective, laparoscopic fenestration can be considered as a treatment option. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
111. Severe Renal Hemorrhage in a Pregnant Woman Complicated with Antiphospholipid Syndrome: A Case Report
- Author
-
Kawaguchi, Shohei, Izumi, Kouji, Nohara, Takahiro, Miyagi, Tohru, Konaka, Hiroyuki, Mizokami, Atsushi, Koh, Eitetsu, and Namiki, Mikio
- Subjects
Article Subject - Abstract
Antiphospholipid syndrome is a systemic autoimmune disease with thrombotic tendency. Consensus guidelines for pregnancy with antiphospholipid syndrome recommend low-dose aspirin combined with unfractionated or low-molecular-weight heparin because antiphospholipid syndrome causes habitual abortion. We report a 36-year-old pregnant woman diagnosed with antiphospholipid syndrome receiving anticoagulation treatment. The patient developed left abdominal pain and gross hematuria at week 20 of pregnancy. An initial diagnosis of left ureteral calculus was made. Subsequently abdominal-pelvic computed tomography was required for diagnosis because of the appearance of severe contralateral pain. Computed tomography revealed serious renal hemorrhage, and ureteral stent placement and pain control by patient-controlled analgesia were required. After treatment, continuance of pregnancy was possible and vaginal delivery was performed safely. This is the first case report of serious renal hemorrhage in a pregnant woman with antiphospholipid syndrome receiving anticoagulation treatment and is an instructive case for urological and obstetrical practitioners.
- Published
- 2011
- Full Text
- View/download PDF
112. FUNDAMENTAL STUDY ON APPLICABILITY OF ISOLATION STRUCTURE AGAINST EARTHQUAKE MOTION AND TSUNAMI BY UTILIZING ASPHALTIC VISCOUS FLUID
- Author
-
TAKEWUCHI, Mikio, primary, ARIGA, Yoshiaki, additional, WATANABE, Takashi, additional, KAWAGUCHI, Shohei, additional, NISHIMOTO, Yasushi, additional, HORI, Muneo, additional, and ARIKAWA, Taro, additional
- Published
- 2015
- Full Text
- View/download PDF
113. Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp
- Author
-
Nakashima, Kazufumi, primary, Shigehara, Kazuyoshi, additional, Kawaguchi, Shohei, additional, Wakatsuki, Akira, additional, Kobori, Yoshitomo, additional, Nakashima, Kazuyoshi, additional, Ishii, Yasunori, additional, Shimamura, Masayoshi, additional, Sasagawa, Toshiyuki, additional, Kitagawa, Yasuhide, additional, Mizokami, Atsushi, additional, and Namiki, Mikio, additional
- Published
- 2014
- Full Text
- View/download PDF
114. 2P320 DNA motions near a nanopore with a voltage controlled gate embedded in dielectrics(28. Bioengineering,Poster,The 52nd Annual Meeting of the Biophysical Society of Japan(BSJ2014))
- Author
-
Kawaguchi, Shohei, primary, Kato, Yuta, additional, Shibasaki, Kensaku, additional, Ishida, Kentaro, additional, and Mitsui, Toshiyuki, additional
- Published
- 2014
- Full Text
- View/download PDF
115. 2P319 DNA dynamics and translocations though solid-state nanopore and nanoslit(28. Bioengineering,Poster,The 52nd Annual Meeting of the Biophysical Society of Japan(BSJ2014))
- Author
-
Kato, Yuta, primary, Kawaguchi, Shohei, additional, Shibasaki, Kensaku, additional, Ishida, Kentaro, additional, and Mitsui, Toshiyuki, additional
- Published
- 2014
- Full Text
- View/download PDF
116. Cytological evaluation using liquid‐based cytology in the male urogenital tract infected with human papillomavirus
- Author
-
Shigehara, Kazuyoshi, primary, Sasagawa, Toshiyuki, additional, Kawaguchi, Shohei, additional, Nakashima, Kazufumi, additional, Nakashima, Takao, additional, Shimamura, Masayoshi, additional, Furubayashi, Keiichi, additional, and Namiki, Mikio, additional
- Published
- 2013
- Full Text
- View/download PDF
117. Evaluation of PDN impedance and power supply noise for different on-chip decoupling structures
- Author
-
Fujita, Haruya, primary, Takatani, Hiroki, additional, Tanaka, Yosuke, additional, Kawaguchi, Shohei, additional, Sato, Masaomi, additional, and Sudo, Toshio, additional
- Published
- 2013
- Full Text
- View/download PDF
118. Correlation of PDN impedance between measurements and simulation of 3D-SiP
- Author
-
Kawaguchi, Shohei, primary, Sato, Masaomi, additional, Takatani, Hiroki, additional, Tanaka, Yosuke, additional, Fujita, Haruya, additional, Suto, Yoichi, additional, and Sudo, Toshio, additional
- Published
- 2013
- Full Text
- View/download PDF
119. Japan Cancer of the Prostate Risk Assessment for combined androgen blockade including bicalutamide: Clinical application and validation
- Author
-
Kitagawa, Yasuhide, primary, Hinotsu, Shiro, additional, Shigehara, Kazuyoshi, additional, Nakashima, Kazufumi, additional, Kawaguchi, Shohei, additional, Yaegashi, Hiroshi, additional, Mizokami, Atsushi, additional, Akaza, Hideyuki, additional, and Namiki, Mikio, additional
- Published
- 2012
- Full Text
- View/download PDF
120. Predictor of de novo stress urinary incontinence following TVM procedure: a further analysis of preoperative voiding function
- Author
-
Kuribayashi, Masato, primary, Kitagawa, Yasuhide, additional, Narimoto, Kazutaka, additional, Urata, Satoko, additional, Kawaguchi, Shohei, additional, and Namiki, Mikio, additional
- Published
- 2012
- Full Text
- View/download PDF
121. Liquid-Based Urine Cytology as a Tool for Detection of Human Papillomavirus, Mycoplasma spp., and Ureaplasma spp. in Men
- Author
-
Kawaguchi, Shohei, primary, Shigehara, Kazuyoshi, additional, Sasagawa, Toshiyuki, additional, Shimamura, Masayoshi, additional, Nakashima, Takao, additional, Sugimoto, Kazuhiro, additional, Nakashima, Kazufumi, additional, Furubayashi, Keiichi, additional, and Namiki, Mikio, additional
- Published
- 2012
- Full Text
- View/download PDF
122. STABILITY EVALUATION OF METAL CASK ATTACHED TO A TRANSFER PALLET DURING LONG-PERIOD SEISMIC MOTIONS
- Author
-
KAWAGUCHI, Shohei, primary, SHIRAI, Koji, additional, and KANAZAWA, Kenji, additional
- Published
- 2012
- Full Text
- View/download PDF
123. Immediate Effect on Overactive Bladder Symptoms following Administration of Imidafenacin
- Author
-
Kitagawa, Yasuhide, primary, Kuribayashi, Masato, additional, Narimoto, Kazutaka, additional, Kawaguchi, Shohei, additional, Yaegashi, Hiroshi, additional, and Namiki, Mikio, additional
- Published
- 2011
- Full Text
- View/download PDF
124. Etiological role of human papillomavirus infection for inverted papilloma of the bladder
- Author
-
Shigehara, Kazuyoshi, primary, Sasagawa, Toshiyuki, additional, Doorbar, John, additional, Kawaguchi, Shohei, additional, Kobori, Yoshitomo, additional, Nakashima, Takao, additional, Shimamura, Masayoshi, additional, Maeda, Yuji, additional, Miyagi, Tohru, additional, Kitagawa, Yasuhide, additional, Kadono, Yoshifumi, additional, Konaka, Hiroyuki, additional, Mizokami, Atsushi, additional, Koh, Eitetsu, additional, and Namiki, Mikio, additional
- Published
- 2010
- Full Text
- View/download PDF
125. Etiologic role of human papillomavirus infection in bladder carcinoma
- Author
-
Shigehara, Kazuyoshi, primary, Sasagawa, Toshiyuki, additional, Kawaguchi, Shohei, additional, Nakashima, Takao, additional, Shimamura, Masayoshi, additional, Maeda, Yuji, additional, Konaka, Hiroyuki, additional, Mizokami, Atsushi, additional, Koh, Eitetsu, additional, and Namiki, Mikio, additional
- Published
- 2010
- Full Text
- View/download PDF
126. Comprehensive analysis of perioperative hypotension in photodynamic diagnosis‐assisted transurethral resection of bladder tumor with 5‐aminolevulinic acid.
- Author
-
Nohara, Takahiro, Takimoto, Atsuya, Shinzawa, Rei, Kurauchi, Daimon, Toriumi, Ren, Nakagawa, Ryunosuke, Aoyama, Shuhei, Kamijima, Taiki, Kano, Hiroshi, Naito, Renato, Kadomoto, Suguru, Iwamoto, Hiroaki, Yaegashi, Hiroshi, Kawaguchi, Shohei, Shigehara, Kazuyoshi, Izumi, Kouji, and Mizokami, Atsushi
- Subjects
- *
TRANSURETHRAL resection of bladder , *ORAL drug administration , *SPINAL anesthesia , *KIDNEY physiology , *GENERAL anesthesia , *BLADDER cancer - Abstract
Objective: Intraoperative hypotension remains a serious adverse event of photodynamic diagnosis‐assisted transurethral resection of bladder tumor with oral administration of 5‐aminolevulinic acid. We conducted a re‐analysis of perioperative hypotension in photodynamic diagnosis‐assisted transurethral resection of the bladder tumor with oral 5‐aminolevulinic acid to ascertain its safety. Methods: A total of 407 cases who underwent transurethral resection of bladder tumors in our institution were reviewed (274 cases for the PDD group with photodynamic diagnosis and 133 for the white light (WL) group without). A classification of hypotension severity was devised to identify risk factors for clinically troublesome hypotension. The distribution of hypotension severity in each of the PDD and WL groups was compared. Additionally, the patient background and perioperative data by hypotension severity were compared only in the PDD group. Results: More patients with moderate and severe hypotension were noted in the PDD group. The renal function was lower with increasing hypotension severity in the PDD group. More patients on general anesthesia were included in the mild and moderate hypotension group, whereas more patients on spinal anesthesia were included in the severe hypotension group. Furthermore, the frequency of side effects other than hypotension tended to increase with hypotension severity. Conclusions: Renal function impairment and the other adverse effects of 5‐aminolevulinic acid may be risk factors for severe hypotension. Mild or moderate hypotension may be caused by general anesthesia and severe hypotension may be caused by spinal anesthesia. To elucidate specific risk factors, further case–control studies are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
127. Liquid-Based Urine Cytology as a Tool for Detection of Human Papillomavirus, Mycoplasmaspp., and Ureaplasmaspp. in Men
- Author
-
Kawaguchi, Shohei, Shigehara, Kazuyoshi, Sasagawa, Toshiyuki, Shimamura, Masayoshi, Nakashima, Takao, Sugimoto, Kazuhiro, Nakashima, Kazufumi, Furubayashi, Keiichi, and Namiki, Mikio
- Abstract
ABSTRACTLiquid-based urine cytology (LB-URC) was evaluated for cytological diagnosis and detection of human papillomavirus (HPV), Mycoplasma, and Ureaplasma. Midstream urine samples were collected from 141 male patients with urethritis and 154 controls without urethritis, and sediment cells were preserved in liquid-based cytology solution. Urethral swabs from urethritis patients were tested for the presence of Neisseria gonorrhoeaeand Chlamydia trachomatis. Papanicolaou tests were performed for cytological evaluation. HPV, Mycoplasma, and Ureaplasmagenomes were determined by PCR-based methods, and localization of HPV DNA in urothelial cells was examined by in situhybridization (ISH). The ß-globin gene was positive in 97.9% of LB-URC samples from urethritis patients and in 97.4% of control samples, suggesting that high-quality cellular DNA was obtained from the LB-URC samples. HPV DNA was detected in 29 (21.0%) urethritis cases and in five (3.3%) controls (P< 0.05). HPV type 16 (HPV 16) was most commonly found in urethritis patients. Cytological evaluations could be performed for 92.1% of urethritis patients and 64.3% of controls. Morphological changes suggestive of HPV infection were seen in 20.7% of the HPV-positive samples, and ISH demonstrated the presence of HPV DNA in both squamous and urothelial cells in HPV-positive samples. Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum, and Ureaplasma urealyticumwere detected in 14.5%, 10.9%, 6.5%, and 12.3% of urethritis patients, respectively. The prevalence rates of these microorganisms (except Ureaplasma parvum) were significantly higher in urethritis cases than controls (P< 0.05). LB-URC is applicable for detection of HPV, Mycoplasma, and Ureaplasma.HPV infection occurs in urothelial cells, especially in gonococcal urethritis.
- Published
- 2012
- Full Text
- View/download PDF
128. Investigating the mechanism underlying urinary continence using dynamic MRI after Retzius-sparing robot-assisted radical prostatectomy.
- Author
-
Kadono, Yoshifumi, Nohara, Takahiro, Kawaguchi, Shohei, Kadomoto, Suguru, Iwamoto, Hiroaki, Iijima, Masashi, Shigehara, Kazuyoshi, Izumi, Kouji, Yoshida, Kotaro, Gabata, Toshifumi, and Mizokami, Atsushi
- Subjects
- *
SURGICAL robots , *RADICAL prostatectomy , *URINARY stress incontinence , *MAGNETIC resonance imaging , *URETHRA , *URINARY incontinence , *POSTOPERATIVE period - Abstract
Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) exhibits better postoperative urinary continence than conventional RARP (C-RARP) via the anterior approach. However, the reasons behind this are unknown. Herein, early postoperative urinary incontinence and anatomical differences of 51 propensity score-matched C-RARP and RS-RARP cases were compared. Dynamic magnetic resonance imaging (MRI) was performed before and after surgery to examine the pelvic anatomical changes under abdominal pressure. The median urine loss ratios in the early postoperative period after C-RARP and RS-RARP were 11.0% and 1.0%, respectively. Postoperative MRI revealed that the anterior bladder wall was fixed in a higher position after RS-RARP compared with its position after C-RARP. Dynamic MRI after C-RARP showed that cephalocaudal compression of the bladder while applying abdominal pressure caused the membranous urethra to expand and the urine to flow out. After RS-RARP, the rectum moved forward during abdominal pressure, and the membranous urethra was compressed by closure from behind. This is the first study using dynamic MRI to reveal the importance of high attachment of the anterior bladder wall for the urethral closure mechanism during abdominal pressure. RS-RARP, which can completely preserve this mechanism, is less likely to cause stress urinary incontinence compared with C-RARP. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
129. Does radical cystectomy have a better prognosis than bladder conservative treatment in the real world?
- Author
-
Nakagawa, Ryunosuke, Izumi, Kouji, Toriumi, Ren, Aoyama, Shuhei, Kamijima, Taiki, Makino, Tomoyuki, Naito, Renato, Iwamoto, Hiroaki, Yaegashi, Hiroshi, Kawaguchi, Shohei, Shigehara, Kazuyoshi, Nohara, Takahiro, and Mizokami, Atsushi
- Subjects
- *
BLADDER cancer , *CONSERVATIVE treatment , *ILEAL conduit surgery , *CYSTECTOMY , *PROGNOSIS , *BLADDER , *LENGTH of stay in hospitals - Abstract
Purpose: To compare the prognosis and quality of life between radical cystectomy and bladder conservative treatment for muscle invasive bladder cancer in the real world. Materials and Methods: Patients treated for muscle invasive bladder cancer without metastases were retrospectively evaluated for overall survival, progression‐free survival, and rehospitalization. Results: Of the 141 patients, 62 underwent bladder conservative treatment and 79 underwent radical cystectomy. Patients who underwent radical cystectomy had significantly better progression‐free survival (HR: 1.83, 95% CI: 1.12–3.00; p < 0.01) and overall survival (HR: 1.82, 95% CI: 0.99–3.34; p = 0.03) than those who underwent conservative treatment. However, there was no significant difference in prognosis between patients who refused to undergo radical cystectomy and those who underwent. In addition, rehospitalization rates for complications and additional treatment were significantly higher in patients who received conservative treatment (69.3% vs. 34.2%; p < 0.01), and the length of hospital stay was also prolonged compared to patients who received radical cystectomy (26 vs. 9 days; p = 0.03). Conclusions: Overall, conservative treatment had a significantly poorer prognosis than radical cystectomy, but there was no significant difference in prognosis when comparing patients who refused radical cystectomy and received conservative treatment with those who received radical cystectomy. However, hospitalization rates and length of stay were significantly worse for patients who chose conservative treatment, which may lead to a decline in quality of life. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
130. Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy.
- Author
-
Kano, Hiroshi, Kadono, Yoshifumi, Naito, Renato, Makino, Tomoyuki, Iwamoto, Hiroaki, Yaegashi, Hiroshi, Kawaguchi, Shohei, Nohara, Takahiro, Shigehara, Kazuyoshi, Izumi, Kouji, and Mizokami, Atsushi
- Subjects
- *
CASTRATION-resistant prostate cancer , *SURGICAL robots , *CANCER relapse , *ACADEMIC medical centers , *PROSTATE-specific antigen , *SALVAGE therapy , *RADICAL prostatectomy , *RETROSPECTIVE studies , *DESCRIPTIVE statistics , *MULTIVARIATE analysis , *PROGRESSION-free survival , *PATIENT aftercare , *OVERALL survival - Abstract
Simple Summary: The efficacy of intermittent androgen deprivation therapy (ADT) for biochemical recurrence (BCR) after robot-assisted radical prostatectomy (RARP) is unknown, and its usefulness in Japanese practice needs to be investigated. A retrospective analysis of 85 patients who underwent RARP at Kanazawa University Hospital between 2009 and 2019 and were selected for intermittent ADT for postoperative recurrence was analyzed. The 5-year castration-resistant prostate-cancer-free survival rates, cancer-specific survival, and overall survival were 92.7%, 98.3%, and 94.7%, respectively. A subgroup analysis of 69 patients who completed initial ADT was conducted to evaluate the rate of BCR following initial ADT. The 5-year BCR-free survival rate was 53.2%. Multivariate analysis identified testosterone ≤ 0.03 ng/mL during ADT as the sole predictor of BCR after ADT. ADT may be applicable for BCR after RARP, and strong testosterone suppression could lead to better outcomes. Background: The efficacy of intermittent androgen deprivation therapy (ADT) for biochemical recurrence (BCR) after robot-assisted radical prostatectomy (RARP) is unknown, and its usefulness in Japanese practice needs to be investigated. Methods: We conducted a retrospective analysis of 85 patients who underwent RARP and were selected for intermittent ADT for postoperative recurrence at Kanazawa University Hospital between 2009 and 2019. Intermittent ADT was administered for 2 years. If prostate-specific antigen levels increased post-treatment, intermittent ADT was reinitiated. The median follow-up period was 47 months. Results: The 73 patients had completed the initial course of ADT, and 12 were under initial ADT. The 5-year castration-resistant prostate-cancer-free survival rates, cancer-specific survival, and overall survival were 92.7%, 98.3%, and 94.7%, respectively. A subgroup analysis of 69 patients who completed intermittent ADT was conducted to evaluate the BCR rate following initial ADT. The 5-year BCR-free survival rate was 53.2%. Multivariate analysis identified testosterone ≤ 0.03 ng/mL during ADT as the sole predictor of BCR after ADT. Conclusions: Salvage intermittent ADT may be an effective treatment option for BCR after RARP. In addition, it would be useful to confirm strong testosterone suppression as a criterion for transition to intermittent therapy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
131. Comparing ceftolozane/tazobactam versus piperacillin/tazobactam for the initial empiric therapy of urinary tract infections: A retrospective comparative study.
- Author
-
Nakagawa, Tomomi, Shigehara, Kazuyoshi, Shinzawa, Rei, Yaegashi, Hiroshi, Kawaguchi, Shohei, Nohara, Takahiro, Izumi, Kouji, and Mizokami, Atsushi
- Subjects
- *
URINARY tract infections , *TAZOBACTAM , *PIPERACILLIN , *ENTEROCOCCUS faecalis , *BACTERIAL cultures , *COMPARATIVE studies - Abstract
This study compares the clinical and microbiological efficacy of ceftolozane/tazobactam (CTLZ/TAZ) and piperacillin/tazobactam (PIPC/TAZ) for treating complicated cystitis or acute pyelonephritis. Patients who had been treated with empiric antibiotics, CTLZ/TAZ (52 cases) or PIPC/TAZ (47 cases), due to urinary tract infections (UTIs) were eligible for this study. Patients' demographic backgrounds, types of UTIs, and causative microorganisms isolated from urine or blood bacterial cultures were collected. Short-term clinical efficacy at the end of the initial empiric therapy, long-term clinical efficacy including sequential antibiotic treatments (nonrecurrence rate within 1 month after the initial empiric therapy), and microbiological efficacy were retrospectively compared in both CTLZ/TAZ and PIPC/TAZ groups. Complicated UTIs were present in most eligible patients, and no significant difference in the patients' background was observed between the two groups. Escherichia coli and Enterococcus faecalis were the most common microorganisms isolated from urine culture in both groups. The short-term clinical effective rate of CTLZ/TAZ and PIPC/TAZ was 80.8% and 87.2%, respectively. For long-term clinical efficacy, the nonrecurrence rate of UTIs was present in 95.1% and 89.7% of patients with CTLZ/TAZ and PIPC/TAZ, respectively. No significant difference was observed in the short- and long-term effects between the two groups. The microbiological efficacy of the CTLZ/TAZ and PIPC/TAZ groups was 72.7% and 86.0%, respectively. No significant difference in microbiological effects was also observed between the two groups. This study demonstrated the noninferiority of CTLZ/TAZ to PIPC/TAZ, suggesting that CTLZ/TAZ is an alternative antibiotic used as empiric therapy for UTIs. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
132. The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.
- Author
-
Makino, Tomoyuki, Sakurai, Takayuki, Takamatsu, Shigeyuki, Iwamoto, Hiroaki, Yaegashi, Hiroshi, Iijima, Masashi, Kawaguchi, Shohei, Nohara, Takahiro, Shigehara, Kazuyoshi, Izumi, Kouji, Kadono, Yoshifumi, and Mizokami, Atsushi
- Subjects
- *
EXTERNAL beam radiotherapy , *HIGH dose rate brachytherapy , *PROSTATE cancer , *RADIOISOTOPE brachytherapy , *TREATMENT effectiveness , *ANDROGEN deprivation therapy , *SURVIVAL rate - Abstract
Background: No standard treatment exists for locally advanced prostate cancer (PC). This study evaluated the long-term treatment outcomes and toxicity in patients with clinically locally advanced and/or lymph node (LN)-positive PC who underwent high-dose-rate brachytherapy (HDR-BT) with external beam radiotherapy (EBRT). Methods: The treatment outcomes and toxicities of 152 patients with PC who underwent HDR-BT with EBRT and had at least 2 years of observation were examined. The treatment dose was 19- and 13-Gy HDR-BT in two and single fractions, respectively, both combined with external irradiation of 46 Gy in 23 fractions. Long-term androgen deprivation therapy (ADT) for patients harboring very high-risk tumors was used in combination. Results: The median observation period was 59.7 (24.4–182.1) months. The 5-year prostate cancer-specific and recurrence-free (RFS) survival rates were 99.0% and 91.8%, respectively, with only two PC mortalities. When 5-year RFS was examined for each parameter, RFS was significantly lower in pre-radiotherapy (pre-RT) prostate-specific antigen (PSA) > 0.5 ng/mL (77.1%; p = 0.008), and presence of LN metastasis (68.1%; p = 0.017). Multivariable analysis demonstrated that pre-RT PSA (HR, 4.68; 95% CI, 1.39–15.67; p = 0.012) and presence of LN metastasis (HR, 4.70; 95% CI, 1.24–17.74; p = 0.022) were independent recurrence predictors. The 5-year cumulative incidence rate of grade ≥ 2 toxicities in genitourinary and gastrointestinal tracts were 15.4% and 1.3%, respectively. Conclusions: HDR-BT combined with EBRT and long-term ADT shows promising disease control and tolerant toxicities for clinically locally advanced and LN-positive PC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
133. Three-dimensional morphological analysis of spermatogenesis in aged mouse testes.
- Author
-
Nakano, Taito, Nakata, Hiroki, Kadomoto, Suguru, Iwamoto, Hiroaki, Yaegashi, Hiroshi, Iijima, Masashi, Kawaguchi, Shohei, Nohara, Takahiro, Shigehara, Kazuyoshi, Izumi, Kouji, Kadono, Yoshifumi, and Mizokami, Atsushi
- Subjects
- *
SPERMATOGENESIS , *TESTIS , *SEMINIFEROUS tubules , *SERTOLI cells , *MALE infertility , *AGING - Abstract
Spermatogenesis, which is a continuous process from undifferentiated spermatogonia to spermatozoa in the seminiferous tubules, declines with age. To investigate changes in spermatogenesis with aging, we reconstructed the seminiferous tubules of 12 mice aged 12 to 30 months from serial sections and examined age-related and region-specific alterations in the seminiferous epithelium and spermatogenic waves in three dimensions. The basic structure of the seminiferous tubules, including the numbers of tubules, terminating points, branching points, and total tubule length, did not change with age. Age-related alterations in spermatogenesis, primarily assessed by the formation of vacuoles in Sertoli cells, were detected in the seminiferous tubules at 12 months. The proportion of altered tubule segments with impaired spermatogenesis further increased by 24 months, but remained unchanged thereafter. Altered tubule segments were preferentially distributed in tubule areas close to the rete testis and those in the center of the testis. Spermatogenic waves became shorter in length with age. These results provide a basis for examining the decline of spermatogenesis not only with aging, but also in male infertility. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
134. Human papillomavirus detected in sperm of Japanese infertile males affects reproductive parameters.
- Author
-
Kato, Yuki, Shigehara, Kazuyoshi, Nakagawa, Tomomi, Nakata, Hiroki, Iijima, Masashi, Nakashima, Kazufumi, Kawaguchi, Shohei, Izumi, Kouji, Kadono, Yoshifumi, and Mizokami, Atsushi
- Subjects
- *
SPERMATOZOA , *MALE infertility , *REACTIVE oxygen species , *PAPILLOMAVIRUSES , *SPERM motility - Abstract
• Human papillomavirus (HPV) infection of sperm was detected in 12.5% of Japanese infertile men. • HPV-DNA was localized to the head and mid-piece of sperm. • Patients with HPV detected in semen had lower sperm motility and concentration. • Patients with HPV detected in semen had an increase in seminal reactive oxygen species activity. The effects of human papillomavirus (HPV) infection on male reproductive parameters are currently a matter of controversy. In order to clarify the issue in Japanese infertile men, the prevalence and localization of HPV in semen, sperm parameters, and superoxide dismutase (SOD) activity in seminal plasma were examined in 216 Japanese infertile men. DNA was extracted from liquid-based cytological semen samples. The β-globin gene was amplified by polymerase chain reaction (PCR), and HPV-DNA was amplified using nested PCR with MY09/MY11 as outer primers and GP5+/GP6+ as inner primers. HPV genotyping was performed in the HPV-positive samples. In addition, SOD levels in seminal plasma were analysed quantitatively. In-situ hybridization (ISH) was performed to localize HPV-DNA in sperm from HPV-positive samples. Any-risk and high-risk prevalence rates of HPV in semen were 12.5% and 6.9%, respectively. No significant difference in the prevalence of HPV was observed between azoospermic and non-azoospermic subjects. Among non-azoospermic patients, those with HPV detected in semen had significantly lower sperm motility and concentration compared with subjects without HPV detected in semen. SOD levels in seminal plasma were significantly higher in HPV-positive patients compared with HPV-negative patients. ISH analysis of HPV-positive samples revealed that HPV-DNA was localized to the head and mid-piece of sperm. HPV-DNA was present in the sperm of young infertile men. HPV infection of sperm was associated with reduced sperm motility and concentration, and resulted in an increase in seminal SOD activity. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
135. A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study.
- Author
-
Izumi, Kouji, Shima, Takashi, Shigehara, Kazuyoshi, Sawada, Kiyoshi, Naito, Renato, Kato, Yuki, Ofude, Mitsuo, Kano, Hiroshi, Iwamoto, Hiroaki, Yaegashi, Hiroshi, Nakashima, Kazufumi, Iijima, Masashi, Kawaguchi, Shohei, Nohara, Takahiro, Kadono, Yoshifumi, and Mizokami, Atsushi
- Subjects
- *
URETERIC obstruction , *PHYSICIANS , *CANCER treatment , *FOLLOW-up studies (Medicine) , *URETER surgery - Abstract
Emergence of malignant ureteral obstruction (MUO) has been reported as a sign of poor prognosis; however, the distribution of survival time in patients with MUO is considerably wide, and no risk classification score has been constructed. To evaluate whether a novel risk classification score for overall survival that we previously developed, is effective in a large cohort. Investigator-initiated, prospective, multicenter diagnostic/prognostic study was conducted. Patients with MUO were divided into three risk groups based on the score calculated using four prognostic factors (PLaCT: Primary site, Laterality, serum Creatinine level, and Treatment for primary site) at the first visit, and prospective follow-up was performed. Overall survival and ureteral stent failure-free survival of each risk group were compared. In total, 300 patients with 21 different primary sites were enrolled. The numbers of patients in good, intermediate, and poor risk groups were 105, 106, and 89, respectively. Median survival times of patients in good, intermediate, and poor risk groups were 406, 221, and 77 days, respectively (P < 0.0001). In 217 patients with ureteral stenting, median ureteral stent failure-free survival times of good, intermediate, and poor risk groups were 385, 183, and 57 days, respectively (P < 0.0001). Limitations include the limited ethnicity and the extended duration of study enrollment. The novel PLaCT risk classification score could divide MUO patients into three risk groups with distinct survival times and ureteral stent patencies. This score will aid in establishing prognosis and treatment strategy for all physicians engaged in cancer treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
136. Etiological role of human papillomavirus infection in the development of penile cancer.
- Author
-
Sakamoto, Jiro, Shigehara, Kazuyoshi, Nakashima, Kazufumi, Kawaguchi, Shohei, Nakashima, Takao, Shimamura, Masayoshi, Yasuda, Mitsuru, Kato, Taku, Hasegawa, Toru, Kobori, Yoshitomo, Okada, Hiroshi, Deguchi, Takashi, Izumi, Kouji, Kadono, Yoshifumi, and Mizokami, Atsushi
- Subjects
- *
PENILE cancer , *IN situ hybridization , *PAPILLOMAVIRUS diseases , *DIAGNOSTIC immunohistochemistry - Abstract
Highlights • Human papillomavirus (HPV) was detected in 41% of patients with penile cancer. • HPV16 was detected most frequently in penile cancer. • In situ hybridization revealed an HPV-DNA punctate signal in the HPV-positive cases. • P16-INK4a expression was significantly stronger in high-risk HPV-positive cases. • mcm-7 and Ki-67 expression had no correlation with HPV status in penile cancer. Abstract Objective To examine the association between human papillomavirus (HPV) infection and penile cancer among Japanese patients. Methods Thirty-four patients with penile cancer were enrolled in this study. DNA was extracted from paraffin-embedded tumor tissue samples, and HPV-DNA tests and genotyping were performed. For all of the samples, in situ hybridization (ISH) was performed to locate HPV-DNA in tumor tissue. Furthermore, expression levels of p16-INK4a, mini-chromosome maintenance protein 7 (mcm-7), HPV-L1, and Ki-67 were analyzed using immunohistochemical methods. Results HPV and high-risk (HR)-HPV were detected in 14 (41.1%; 95% confidence interval (CI) 24.6–57.7%) and 12 (35.2%; 95% CI 19.2–51.4%) cases, respectively. HPV16 was the most frequently detected HPV type. Among the HR-HPV-positive cases, a punctate HR-HPV-DNA signal pattern was detected by ISH in tumor cell nuclei. P16-INK4a was expressed in 66.7% (95% CI 42.8–90.1%) of HR-HPV-positive cases and was significantly more frequent and stronger in HR-HPV-positive cases than in HPV-negative cases. There was no significant difference in the occurrence or distribution of mcm-7 or Ki-67 expression between HPV-positive and HPV-negative cases. HPV-L1 expression was not observed in any of the cases examined. Conclusions HPV infection may have had an etiological role in 41% of the examined cases of penile cancer in Japan. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
137. Novel Treatment Strategies for Low-Risk Metastatic Castration-Sensitive Prostate Cancer.
- Author
-
Iwamoto H, Hori T, Nakagawa R, Kano H, Makino T, Naito R, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Izumi K, and Mizokami A
- Abstract
Background: The treatment strategy for metastatic castration-sensitive prostate cancer (mCSPC) has changed significantly in recent years. Based on various guidelines, an upfront androgen receptor signaling inhibitor (ARSI) is the first choice, but in patients of Asian descent, including Japanese patients, there are a certain number of cases in which androgen deprivation therapy (ADT) and CAB are more effective. If patients can be identified who show a marked response to ADT within 12 weeks after the initiation of ADT, which is the inclusion criterion for ARSI clinical trials targeting mCSPC, it would be valuable from an economic standpoint., Methods: A total of 218 patients with pure prostate adenocarcinoma and treated with ADT at the Kanazawa University Hospital between January 2000 and December 2020 were included in this study. As a risk classification for mCSPC, in addition to the LATITUDE and CHAARTED criteria, we used the castration-sensitive prostate cancer classification proposed by Kanazawa University (Canazawa), developed by the Department of Urology of Kanazawa University. The Canazawa classification was based on three factors: Gleason pattern 5, bone scan index (BSI) ≥ 1.5, and lactate dehydrogenase (LDH) ≥ 300 IU/L. It defined patients with one factor or less as low-risk and patients with two or three factors as high-risk. The overall survival (OS) and time to castration resistance (TTCR) were estimated retrospectively using the Kaplan-Meier method, and factors associated with TTCR were identified using univariate and multivariate analyses., Results: The median follow-up period was 40.4 months, the median OS period was 85.2 months, and the median TTCR period was 16.4 months. The Canazawa risk classification provided the clearest distinction between the OS and TTCR in mCSPC patients. Multivariate analysis revealed a decrease in PSA levels of <95% at 12 weeks after ADT initiation and was a predictor of short TTCR in low-risk, low-volume patients across all risk classifications., Conclusion: The Canazawa classification differentiated the prognosis of mCSPC patients more clearly. A PSA reduction rate of <95% at 12 w after starting ADT in low-risk, low-volume patients of all risk classifications was significantly shorter than the TTCR. We propose a new treatment strategy, in which patients with low-risk mCSPC are treated with ADT and switched to ARSIs based on the rate of PSA reduction at 12 w.
- Published
- 2024
- Full Text
- View/download PDF
138. A comparison of the efficacy of dutasteride on reducing lower urinary tract symptoms among patients with small versus large benign prostatic hyperplasia.
- Author
-
Shigehara K, Kato Y, Kawaguchi S, Izumi K, Kadono Y, and Mizokami A
- Abstract
Background: Only a few reports have currently studied the efficacy of dutasteride in patients with small benign prostatic hyperplasia (BPH). We investigated the efficacy of dutasteride on reducing lower urinary tract symptoms among them., Materials and Methods: A total of 81 patients with BPH who completed 52weeks of 0.5?mg dutasteride treatment were enrolled. Each patient filled out the International Prostatic Symptom Score (IPSS) and overactive bladder symptom score (OABSS) at baseline and at the 6- and 12-month follow-up visits. Total testosterone, prostate-specific antigen, adenoma/prostate volume (PV), uroflowmetry analysis, and postvoid residual volume were evaluated at baseline and at the 12-month follow-up visit. The enrolled patients were divided into 2 groups according to PV at baseline. The groups were as follows: Group A (PV ≥ 30 mL) and Group B (PV < 30 mL)., Results: Groups A and B had mean PVs of 52.1 and 23.6 mL and mean IPSS scores of 16.7 and 14.4, respectively. Group A had significantly higher OABSS and prostate-specific antigen levels at baseline than Group B, while no significant differences in any other baseline characteristics was observed. After dutasteride treatment, adenoma volume and PV decreased significantly, while testosterone level showed a significant increase in both groups. Group A showed significant improvements in the total IPSS, voiding and storage subscore of the IPSS, OABSS, maximum flow rate, and postvoid residual volume. Group B, on the other hand, also showed significant improvements only in the total IPSS, voiding subscore of the IPSS, and maximum flow rate., Conclusions: The present study suggests a possible beneficial effect of dutasteride treatment on the reduction of lower urinary tract symptoms in patients with small and large BPH. However, the effectiveness of dutasteride was limited compared to patients with large BPH (PV ≥ 30 mL)., Competing Interests: No conflict of interest has been declared by the author., (Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
139. Quantitative susceptibility mapping for susceptibility source separation with adaptive relaxometric constant estimation (QSM-ARCS) from solely gradient-echo data.
- Author
-
Kan H, Uchida Y, Kawaguchi S, Kasai H, Hiwatashi A, and Ueki Y
- Subjects
- Humans, Male, Adult, Female, Brain diagnostic imaging, Young Adult, Brain Mapping methods, Image Processing, Computer-Assisted methods, Magnetic Resonance Imaging methods, White Matter diagnostic imaging, Diffusion Tensor Imaging methods
- Abstract
To separate the contributions of paramagnetic and diamagnetic sources within a voxel, a magnetic susceptibility source separation method based solely on gradient-echo data has been developed. To measure the opposing susceptibility sources more accurately, we propose a novel single-orientation quantitative susceptibility mapping method with adaptive relaxometric constant estimation (QSM-ARCS) for susceptibility source separation. Moreover, opposing susceptibilities and their anisotropic effects were determined in healthy volunteers in the white matter. Multiple spoiled gradient echo and diffusion tensor imaging of ten healthy volunteers was obtained using a 3 T magnetic resonance scanner. After the opposing susceptibility and fractional anisotropy (FA) maps had been reconstructed, the parametric maps were spatially normalized. To evaluate the agreements of QSM-ARCS against the susceptibility source separation method using R2 and R2* maps (χ-separation) by Bland-Altman plots, the opposing susceptibility values were measured using white and deep gray matter atlases. We then evaluated the relationships between the opposing susceptibilities and FAs in the white matter and used a field-to-fiber angle to assess the fiber orientation dependencies of the opposing susceptibilities. The susceptibility maps in QSM-ARCS were successfully reconstructed without large artifacts. In the Bland-Altman analyses, the opposing QSM-ARCS susceptibility values excellently agreed with the χ-separation maps. Significant inverse and proportional correlations were observed between FA and the negative and positive susceptibilities estimated by QSM-ARCS. The fiber orientation dependencies of the negative susceptibility represented a nonmonotonic feature. Conversely, the positive susceptibility increased linearly with the fiber angle with respect to the B0 field. The QSM-ARCS could accurately estimate the opposing susceptibilities, which were identical values of χ-separation, even using gradient echo alone. The opposing susceptibilities might offer direct biomarkers for assessment of the myelin and iron content in glial cells and, through the underlying magnetic sources, provide biologic insights toward clinical transition., Competing Interests: Declaration of competing interest None., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
140. Vein-guided anatomical resection of liver segment III along the left hepatic vein: a feasible procedure?
- Author
-
Kogure M, Hasui N, Kawaguchi S, Kudo S, Momose H, Matsuki R, Suzuki Y, Kogure K, and Sakamoto Y
- Subjects
- Humans, Treatment Outcome, Male, Female, Hepatic Veins surgery, Hepatectomy methods, Liver Neoplasms surgery
- Abstract
Competing Interests: Declaration of competing interest None to declare.
- Published
- 2024
- Full Text
- View/download PDF
141. Therapeutic efficacy and safety of biweekly administration of enfortumab vedotin for urothelial carcinoma.
- Author
-
Nakagawa R, Izumi K, Toriumi R, Aoyama S, Kamijima T, Kano H, Makino T, Naito R, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Nohara T, and Mizokami A
- Abstract
Objectives: Enfortumab vedotin (EV) is an established pharmacotherapy for metastatic urothelial carcinoma (mUC); however, its adverse events (AEs) cannot be overlooked. The study investigated the efficacy and safety of biweekly EV administration., Methods: Patients with mUC who received EV at our institution were included in the study. Eligible patients were classified into two groups as follows: those who received EV on a standard schedule (standard group) and those who received EV on a biweekly schedule (biweekly group); the treatment outcomes and AEs between the two groups were compared., Results: Nine and 19 patients were in the standard group and biweekly groups, respectively. The progression-free survival, overall survival, and overall response rate were not significantly different between the two groups. AEs following EV administration, such as decreased appetite (P < .01), pruritus (P < .01), rash maculopapular (P < .01), anemia (P = .04), and liver dysfunction (P = .04), were significantly more frequent in the standard group. Grade 3 or higher AEs, such as pruritus (P = .03) and rash maculopapular (P < .01), were significantly more frequent in the standard group. Furthermore, significantly more patients in the standard group had to be given a reduced dose due to adverse events (P = .02)., Conclusions: Biweekly administration of EV may be safer without compromising therapeutic efficacy than the standard schedule., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permission@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
142. Rescue of outflow block of the remnant left liver after extended right hemihepatectomy for resection of a tumor in the caudate lobe.
- Author
-
Kawaguchi S, Onozawa S, Momose H, Matsuki R, Kogure M, Suzuki Y, and Sakamoto Y
- Abstract
Outflow block of the liver is a life-threatening event after living donor liver transplantation. Herein, we rescued a patient suffering from the outflow block of the remnant left hemiliver caused by bending of the left hepatic vein (LHV) after right hemihepatectomy plus caudate lobectomy combined with resection of the middle hepatic vein (MHV). A metastatic tumor sized 6 cm in the caudate lobe of the liver involving the root of the MHV was found in a 50's year old patient after resection of a right breast cancer eight years ago. Right hemihepatectomy and caudate lobectomy combined with resection of the MHV was performed using a two-stage hepatectomy (partial TIPE ALPPS). On day 1, the total bilirubin value increased to 4.5 mg/dL, and a dynamic computed tomography (CT) scan showed the bent LHV. On the diagnosis of outflow block of the left liver, a self-expandable metallic stent was placed in the LHV using an interventional approach, and the pressure in the LHV decreased from 27 cmH
2 O to 12 cmH2 O. The bilirubin value decreased to 1.2 mg/dL on day 3. Outflow block of the LHV can happen after extended right hemihepatectomy with resection of the MHV. Early diagnosis and interventional stenting treatment can rescue the patient from congestive liver failure., Competing Interests: The authors have no conflicts of interest to disclose., (2024, National Center for Global Health and Medicine.)- Published
- 2024
- Full Text
- View/download PDF
143. Anisotropy of the R1/T2* value dependent on white matter fiber orientation with respect to the B0 field.
- Author
-
Kawaguchi S, Kan H, Uchida Y, Kasai H, Hiwatashi A, and Ueki Y
- Subjects
- Humans, Young Adult, Adult, Anisotropy, Brain diagnostic imaging, Magnetic Resonance Imaging methods, Brain Mapping methods, White Matter diagnostic imaging
- Abstract
The R1 (1/T1) map divided by the T2* map (R1/T2* map) draws attention as a high-resolution myelin-related map. However, both R1 and R2* (1/T2*) values demonstrate anisotropy dependent on the white matter (WM) fiber orientation with respect to the static magnetic (B0) field. Therefore, this study primarily aimed to investigate the comprehensive impact of these angular-dependent anisotropies on the R1/T2* value. This study enrolled 10 healthy human volunteers (age = 25 ± 1.3) on the 3.0 T MRI system. For R1/T2* map calculation, whole brain R1 and T2* maps were repeatedly obtained in three head tilt positions by magnetization-prepared two rapid gradient echoes and multiple spoiled gradient echo sequences, respectively. Afterward, all maps were spatially normalized and registered to the Johns Hopkins University WM atlas. R1/T2*, R1, and R2* values were binned for fiber orientation related to the B0 field, which was estimated from diffusion-weighted echo-planar imaging data with 3° intervals, to investigate angular-dependent anisotropies in vivo. A larger change in the R1/T2* value in the global WM region as a function of fiber orientation with respect to the B0 field was observed compared to the R1 and R2* values alone. The minimum R1/T2* value at the near magic-angle range was 18.86% lower than the maximum value at the perpendicular angle range. Furthermore, R1/T2* values in the corpus callosum tract and the right and left cingulum cingulate gyrus tracts changed among the three head tilt positions due to fiber orientation changes. In conclusion, the R1/T2* value demonstrates distinctive and complicated angular-dependent anisotropy indicating the trends of both R1 and R2* values and may provide supplemental information for detecting slight changes in the microstructure of myelin and axons., Competing Interests: Declaration of competing interest None., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
144. Does the quality of endoscopic equipment influence the recurrence rate after photodynamic diagnosis-assisted transurethral resection of bladder tumor?
- Author
-
Nakagawa R, Nohara T, Kano H, Makino T, Naito R, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Izumi K, and Mizokami A
- Subjects
- Humans, Male, Female, Aged, Retrospective Studies, Middle Aged, Photosensitizing Agents therapeutic use, Aged, 80 and over, Transurethral Resection of Bladder, Urinary Bladder Neoplasms surgery, Urinary Bladder Neoplasms pathology, Neoplasm Recurrence, Local, Cystoscopy methods
- Abstract
Background: Photodynamic diagnosis-assisted transurethral resection of bladder tumor (PDD-TURBT) for nonmuscle-invasive bladder cancer is superior to conventional white-light TURBT for cancer detection. However, when performing PDD-TURBT, cystoscopy findings vary depending on the quality of the endoscopic equipment. In this study, we compared the effects of different types of endoscopic equipment on postoperative outcomes., Methods: Patients who underwent their first PDD-TURBT at our clinic were selected. Patients on whom PDD-TURBT was performed using endoscopic equipment A were sorted into Group A, and patients on whom PDD-TURBT was performed using equipment S were sorted into Group S. The characteristics, recurrence-free survival (RFS), and recurrence frequency of these patients were retrospectively investigated and compared. The prognostic factors for RFS were also analyzed., Results: A total of 49 patients were included in Group A and 46 in Group S. In Group S, a higher detection rate (8.2% vs. 30.4 %, p < 0.01) of carcinoma in situ (CIS) was noted. RFS tended to be better in Group S (HR 0.63, p = 0.15). The frequency of recurrence also tended to be lower in Group S (4.92 vs. 3.66 per 10,000 person-days, p = 0.08). Furthermore, CIS (HR 0.30, p = 0.04) and Bacillus Calmette-Guerin therapy (HR: 0.26, p = 0.01) were significant favorable prognostic factors for RFS., Conclusion: The quality of the endoscopic equipment may influence postoperative recurrence after PDD-TURBT. Higher-quality endoscopic instruments have superior CIS detection capabilities, which can lead to improvements in postoperative outcomes with the appropriate selection of postoperative adjuvant therapy., Competing Interests: Declaration of competing interest All authors declare that there are no potential conflicts of interest relevant to this article., (Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
145. Procalcitonin in advanced urological cancer-bacterial versus non-bacterial infections: prospective cohort study.
- Author
-
Yaegashi H, Izumi K, Toriumi R, Aoyama S, Kamijima T, Kano H, Makino T, Naito R, Iwamoto H, Kawaguchi S, Nohara T, Shigehara K, and Mizokami A
- Abstract
Objectives: Patients with advanced cancer may develop bacterial infections (BI) as their general condition worsens, but general blood tests often find it difficult to distinguish them from non-bacterial infections (NBI). The present prospective study was undertaken to investigate the effectiveness of serum procalcitonin levels in distinguishing between BI and NBI in patients with advanced urological cancer., Methods: This study prospectively evaluated patients diagnosed with locally advanced or metastatic or recurrent urological cancer in our department from September 2013 to December 2019. Body temperature was measured in the axilla and the measurement results were recorded. Febrile episodes of ≥38.0°C were analysed, and written patient consent was obtained at the onset of the fever., Results: Of 75 patients enrolled in the present study, 90 febrile episodes were analysed. A total of 34 of 90 febrile episodes were regarded as BI, and the remaining 56 febrile episodes as NBI. The median procalcitonin value was significantly higher in the BI group (p=0.0015), while no significant difference was found between the two groups for white blood cell count and C reactive protein. Additionally, a white blood cell count of less than 1.0×10ˆ9/L resulted in BI in all cases. The procalcitonin receiver operating characteristic area under the curve was 0.710 (95% CI 0.586 to 0.83), excluding cases with white blood cell counts of <1.0 × 10
3 /μL., Conclusions: Procalcitonin is a rapid and affordable marker for differentiation between BI and NBI in patients with advanced urological cancer., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2024
- Full Text
- View/download PDF
146. A seed link connector protruding into the bladder formed a bladder stone.
- Author
-
Aoyama S, Izumi K, Makino T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Nohara T, and Mizokami A
- Abstract
Introduction: Low-dose-rate brachytherapy is performed for localized prostate cancer. We report the first case of a bladder stone encompassing the seed migrated into the bladder in a patient treated with low-dose-rate brachytherapy., Case Presentation: A man was diagnosed with prostate cancer and underwent low-dose-rate brachytherapy. After 2 months, dysuria occurred, and ultrasonography revealed a needle-shaped high-intensity protruding from the prostate into the bladder. Cystoscopy examination found a seed link connector. With the possibility of natural dissolution of the seed link, careful observation was chosen. However, 16 months later, hematuria occurred, and an X-ray revealed a bladder stone encompassing the seed. Compared with the X-ray right after seeding, the seed located near the right bladder neck had fallen. The seed was removed by transurethral bladder lithotripsy., Conclusion: Seeds should be carefully located within the prostate, otherwise a bladder stone may be formed encompassing the seed., Competing Interests: The authors declare no conflict of interest., (© 2024 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association.)
- Published
- 2024
- Full Text
- View/download PDF
147. Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer.
- Author
-
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Makino T, Naito R, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Nohara T, and Mizokami A
- Abstract
Bone is a common site of prostate cancer metastasis. Bone turnover markers n-terminal propeptide of type I procollagen (P1NP) and tartrate-resistant acid phosphatase type 5b (TRACP-5b) are highly sensitive to bone remodeling activity. However, their prognostic significance as markers of prostate cancer is unknown. This study retrospectively examined the usefulness of P1NP and TRACP-5b as prognostic biomarkers. Castration-resistant prostate cancer recurrence-free survival (CFS) was estimated using the Kaplan-Meier method. A predictive model for CFS was constructed using multivariate analysis. This study enrolled 255 patients diagnosed with prostate cancer at Kanazawa University Hospital. The median follow-up was 115.1 months. Patients with both high serum P1NP and TRACP-5b levels, defined as having a poor bone turnover category (BTC), had significantly shorter CFS. Multivariate analysis identified Gleason score, metastasis, and BTC poor as predictors for castration resistance in prostate cancer. Using these three factors, a prognostic model was established, categorizing patients into low-risk (no or one factor) and high-risk (two or three factors) groups. In the low-risk group, the median CFS was not reached, contrasting with 19.1 months in the high-risk group (hazard ratio, 32.23, p < 0.001). Combining P1NP and TRACP-5b may better predict castration resistance.
- Published
- 2024
- Full Text
- View/download PDF
148. Role of Positive Biopsy Core Ratio in Prostate Cancer Patients.
- Author
-
Kano H, Izumi K, Nakagawa R, Toriumi R, Aoyama S, Kamijima T, Shimada T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Nohara T, Shigehara K, Kadono Y, and Mizokami A
- Subjects
- Male, Humans, Androgen Antagonists therapeutic use, Retrospective Studies, Prostate pathology, Prostate-Specific Antigen, Biopsy, Prostatic Neoplasms pathology
- Abstract
Background/aim: The percentage of positive cores (PPC) is increasingly recognized as a prognostic factor in prostate cancer. However, the usefulness of PPC for patients undergoing androgen deprivation therapy (ADT) and high-risk group has not been adequately studied., Patients and Methods: A retrospective analysis was conducted of 255 patients who underwent prostate biopsy (all-case group). We examined the efficacy of PPC as a prognostic biomarker., Results: Eighty-nine patients were treated with ADT alone (ADT group), and 107 patients were classified as high-risk (high-risk group). The median duration of follow-up was 112.4 months, 85.3 months, and 110.0 months for the all-case, ADT, and high-risk groups, respectively. Patients with PPC >60% had significantly shorter prostate cancer-specific survival (CSS) and castration-resistant prostate cancer-free survival (CFS) in the all-case and ADT groups. In the high-risk group, patients with PPC >60% had shorter CFS but no difference in CSS. Multivariate analysis showed that significant independent predictors of prostate CSS were the presence of metastasis at diagnosis and PPC >60% in the all-case and ADT groups., Conclusion: PPC may be a prognostic factor in ADT treated and high-risk prostate patients., (Copyright © 2023 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
149. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
- Author
-
Nakagawa R, Nohara T, Naito R, Kadomoto S, Iwamoto H, Yaegashi H, Kawaguchi S, Shigehara K, Izumi K, Kadono Y, and Mizokami A
- Subjects
- Humans, BCG Vaccine therapeutic use, Retrospective Studies, Transurethral Resection of Bladder, Photosensitizing Agents therapeutic use, Neoplasm Recurrence, Local prevention & control, Neoplasm Recurrence, Local pathology, Neoplasm Invasiveness pathology, Photochemotherapy methods, Urinary Bladder Neoplasms drug therapy, Urinary Bladder Neoplasms surgery
- Abstract
Background: Intravesical Bacille Calmette-Guerin (BCG) therapy has been reported to be effective in preventing recurrence and progression in non-muscle invasive bladder cancer. Furthermore, photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) improves the accuracy of cancer diagnosis and contributes to lower recurrence rates. The purpose of this study is to investigate whether more tumor resection with PDD-TURBT rather than conventional TURBT before BCG therapy outweighs the benefit of BCG therapy alone., Methods: Patients who underwent intravesical BCG therapy following TURBT in our institution from 2010 to 2021 were included. They were divided into the following two groups: those who received PDD-TURBT before BCG treatment (PDD + BCG group) and those who received conventional TURBT before BCG treatment (WL + BCG group). The 2-year recurrence-free survival (RFS) and progression-free survival (PFS) of the two groups were retrospectively analyzed and compared., Results: The 2-year RFS was significantly improved in the PDD + BCG group (hazard ratio [HR]: 2.41, 95% confidence interval [CI]: 1.26-4.60; p = 0.025). No significant difference in 2-year PFS was noted between the two groups. Analysis of prognostic factors for RFS showed that PDD-TURBT w We think that this text does not adequately express the meaning that we want to deliver to the reader.as a significant prognostic factor in univariate analysis (HR: 0.41, 95% CI: 0.18-0.92; p = 0.03)., Conclusion: BCG treatment following PDD-TURBT significantly improved RFS more than BCG therapy following WL-TURBT. More accurate tumor localization and more efficient tumor resection by PDD-TURBT may have a positive impact on subsequent BCG treatments even if the treatment is administered postoperatively., Competing Interests: Declaration of Competing Interest All authors declare that there are no potential conflicts of interest relevant to this article., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
150. Factors Affecting Prostate Displacement During Volumetric Modulated Arc Therapy in Prone Position After High-Dose-Rate Brachytherapy for Prostate Cancer.
- Author
-
Sakurai T, Takamatsu S, Shibata S, Minamikawa R, Yamazaki M, Kojima H, Noto K, Makino T, Kawaguchi S, Nohara T, Mizokami A, and Gabata T
- Abstract
Purpose: In irradiating the prostate and pelvic lymph node regions, registration based on bony structures matches the pelvic lymph node regions but not necessarily the prostate position, and it is important to identify factors that influence prostate displacement. Therefore, we investigated factors influencing prostate displacement during volumetric modulated arc therapy after single-fraction high-dose-rate brachytherapy (HDR-BT) for prostate cancer and the trends in displacement for each fraction., Methods and Materials: Seventy patients who underwent pelvic volumetric modulated arc therapy of 46 Gy in the prone position 15 days after 13 Gy HDR-BT were included. Prostate displacement relative to bony structures was calculated using cone beam computed tomography. Systematic error (SE) and random error (RE) were evaluated in the right-left (RL), craniocaudal (CC), and anteroposterior (AP) directions. The association with clinical and anatomic factors on the planning computed tomography or magnetic resonance imaging was analyzed. Prostate volume change (PVC) was defined as the volume change at 2 days after HDR-BT. Displacement trends were individually examined from the first to 23rd fractions., Results: The mean SE in the RL, CC, and AP directions was -0.01 mm, -2.34 mm, and -0.47 mm, respectively. The root mean square of the RE in the RL, CC, and AP directions was 0.44 mm, 1.14 mm, and 1.10 mm, respectively. SE in the CC direction was independently associated with bladder volume ( P = .021, t statistic = 2.352) and PVC ( P < .001, t statistic = -8.526). SE in the AP direction was independently associated with bladder volume ( P = .013, t statistic = -2.553), PVC ( P < .001, t statistic = 5.477), and rectal mean area ( P = .008, t statistic = 2.743). RE in the CC direction was independently associated with smoking ( P = .035). RE in the AP direction was associated with PVC ( P = .043). Gradual displacement caudally and posteriorly occurred during the irradiation period., Conclusions: Anatomic characteristics of the bladder, rectum, and prostate predict SE. Smoking and PVC predict RE. In particular, whether PVC is ≥140% affects setting internal margins., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.